Multi-center MRD Registry for Inflammatory Breast Cancer
Start Date
5/5/2025
Completion Date
5/31/2032
Summary
To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.
Detailed Description
Primary Objectives -To determine the incidence of protocol specified pre-surgery MRD-positivity in IBC (assessment between completion of planned systemic therapy and surgery). Secondary Objectives * To establish the feasibility of multi-institutional MRD data collection using standard of care Signatera analysis in IBC participants. * To evaluate the association of pre-surgery MRD to pathologic response. * To evaluate participant reported QOL for worry about recurrence based in participants receiving MRD results * To establish protocol-optional baseline and longitudinal MRD data collection in IBC participants and report the frequency of MRD longitudinally * To determine the median lead time between the first MRD-positive result and clinical recurrence. * To determine whether adjuvant therapies decrease the amount of MRD in participants, and the association with relapse.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Quality-of-life Questionnaire
Conditions
Locations
MD Anderson Cancer Center
Houston, Texas 77030
United States